Global Endocrine Testing Market accounted for US$ 9231.21 million in 2020 and is estimated to be US$ 16618.7 million by 2030 and is anticipated to register a CAGR of 6.10%. The endocrine system comprises hormones and group of glands that carry hormones directly to the circulatory system. Thyroid gland and the adrenal glands are major glands in humans, which operate various body activities such as growth and development, metabolism, reproduction, stimuli response, and homeostasis. Imbalance in hormone concentration leads to certain disorder, which can be used as marker to diagnose certain condition. Endocrine testing involves testing of the hormones such as thyroid stimulating hormone, insulin, human chorionic gonadotropin, follicle stimulating hormones, progesterone, cortisol, prolactin, testosterone, and other hormones.

Analyst View:

The market is primarily driven by the rising frequency of endocrine disorders and developments in diagnostic technology. Furthermore, the market is expected to develop due to an ageing population and increased knowledge about early diagnosis and treatment around the world. The measurement of hormone levels secreted by the endocrine glands and the identification of numerous illnesses such as obesity, diabetes, and thyroid disease are all examples of endocrine testing. According to the International Federation, around 463 million adults had diabetes in 2019, with this number expected to climb to 700 million by 2045.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Endocrine Testing Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin, Prolactin, Cortisol DHEA-S, and Others), By Diagnostic Technology (Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and Others), By End User (Hospitals, Diagnostic Laboratories and others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis, and Forecast till 2029”
To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Endocrine-Testing-Market-By-95

Key Market Insights from the report:

Global Endocrine Testing Market accounted for US$ 9231.21 million in 2020 and is estimated to be US$ 16618.7 million by 2030 and is anticipated to register a CAGR of 6.10%. Endocrine testing market is segmented on the basis of test, diagnostic technology, end user, and region.

Based on Test, Global Endocrine Testing Market is segmented into Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin, Prolactin, Cortisol DHEA-S, and Others.
Based on Diagnostic Technology, Global Endocrine Testing Market is segmented into Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and Others.
Based on End-User, Global Endocrine Testing Market is segmented into Hospitals, Diagnostic Laboratories and others.
By Region, the Global Endocrine Testing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report " Global Endocrine Testing Market, By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Luteinizing, Hormone, Estradiol, Testosterone, Progesterone, Human chorionic gonadotropin, Prolactin, Cortisol DHEA-S, and Others), By Diagnostic Technology (Immunoassay, Tandem Mass Spectroscopy, Monoclonal and Polyclonal Antibody, Sensor Technologies, Clinical Chemistry, and Others), By End User (Hospitals, Diagnostic Laboratories and others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis, and Forecast till 2029’’
Key Highlights:

Renalytix AI and Mount Sinai Health System teamed together in July 2020 to research COVID-19 patients' risk of acute and chronic kidney disease. The KidneyIntelX will be used to assess plasma and urine biomarkers in hospitalised patients for the study Prediction of Major Adverse Kidney Events and Recovery (Pred-MAKER).
SphingoTec GmbH introduced the IB10 sphingotest penKid, a CE-IVD-marked point-of-care test for Proenkephalin (penKid), a biomarker that provides real-time monitoring of kidney function with a simple blood test, in January 2020.
Competitive Landscape & their strategies of Global Endocrine Testing Market:

The Key players operating in endocrine testing market include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, and Quest Diagnostics.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Other Topics:https://androidfun.fr/analyse-des-applications-et-du-portefeuille-de-produits-au-cours-de-la-periode-de-prevision-du-marche-de-la-biopsie-liquide/

https://androidfun.fr/apres-leffet-de-verrouillage-et-les-opportunites-sur-le-marche-de-lhormonotherapie-substitutive/

https://androidfun.fr/developpements-cles-et-recents-et-analyse-strategique-du-marche-des-produits-biologiques-pour-le-soin-des-plaies-jusquen-2030/

To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]